Almstead Neil Gregory sold PTCT
April 1, 2026 · Form 4 insider transaction
Almstead Neil Gregory sold 80 shares of PTC Therapeutics, Inc. at $70.30 per share, a transaction worth $5.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
80
Price
$70.30
Total value
$5.6K
InsiderAlmstead Neil Gregory
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after60,137
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025.